speb/financial-data huggingface dataset:
WOCKPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 6570000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 55490000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 660000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 1230000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 12190000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 13420000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 300000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Minority Interest: 3180000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Net Debt: 20110000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 22870000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 9470000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Assets: 5880000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 530000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 153409546.00
WOCKPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 2940000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 1450000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 33180000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Other Intangible Assets: 14570000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 1120000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Liabilities: 700000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 18060000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 1150000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Payables: 6870000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 153409546.00
WOCKPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 33950000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 9470000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 75880000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 46140000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 23430000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 37130000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 38750000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 55800000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 14950000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 100000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: -3720000000.00
WOCKPHARMA.NS income_statement (quarterly, 2024-09-30) — Write Off: 0.00
WOCKPHARMA.NS income_statement (quarterly, 2024-12-31) — +Operating Expense: 4180000000.00
WOCKPHARMA.NS income_statement (quarterly, 2024-12-31) — +Total Revenue: 7210000000.00
WOCKPHARMA.NS income_statement (quarterly, 2024-12-31) — Basic Average Shares: 153846154.00
WOCKPHARMA.NS income_statement (quarterly, 2024-12-31) — Basic EPS: 0.91
WOCKPHARMA.NS income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 2620000000.00
WOCKPHARMA.NS income_statement (quarterly, 2024-12-31) — Depreciation And Amortization In Income Statement: 550000000.00
WOCKPHARMA.NS income_statement (quarterly, 2024-12-31) — Depreciation Income Statement: 550000000.00
WOCKPHARMA.NS income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 153846154.00
WOCKPHARMA.NS income_statement (quarterly, 2024-12-31) — Diluted EPS: 0.91
WOCKPHARMA.NS income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: 140000000.00
WOCKPHARMA.NS income_statement (quarterly, 2024-12-31) — EBIT: 810000000.00
WOCKPHARMA.NS income_statement (quarterly, 2024-12-31) — EBITDA: 1360000000.00
WOCKPHARMA.NS income_statement (quarterly, 2024-12-31) — Gross Profit: 4590000000.00
WOCKPHARMA.NS income_statement (quarterly, 2024-12-31) — Interest Expense: 600000000.00
WOCKPHARMA.NS income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 600000000.00
WOCKPHARMA.NS income_statement (quarterly, 2024-12-31) — Minority Interests: -60000000.00
WOCKPHARMA.NS income_statement (quarterly, 2024-12-31) — Net Income: 140000000.00
WOCKPHARMA.NS income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: 140000000.00
WOCKPHARMA.NS income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: 200000000.00
WOCKPHARMA.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 140000000.00
WOCKPHARMA.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 140000000.00
WOCKPHARMA.NS income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: 200000000.00
WOCKPHARMA.NS income_statement (quarterly, 2024-12-31) — Net Interest Income: -600000000.00
WOCKPHARMA.NS income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -600000000.00
WOCKPHARMA.NS income_statement (quarterly, 2024-12-31) — Normalized EBITDA: 1360000000.00
WOCKPHARMA.NS income_statement (quarterly, 2024-12-31) — Normalized Income: 140000000.00
WOCKPHARMA.NS income_statement (quarterly, 2024-12-31) — Operating Income: 410000000.00
WOCKPHARMA.NS income_statement (quarterly, 2024-12-31) — Operating Revenue: 7210000000.00
WOCKPHARMA.NS income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: 80000000.00
WOCKPHARMA.NS income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 1990000000.00
WOCKPHARMA.NS income_statement (quarterly, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
WOCKPHARMA.NS income_statement (quarterly, 2024-12-31) — Pretax Income: 210000000.00
WOCKPHARMA.NS income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 2620000000.00
WOCKPHARMA.NS income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 550000000.00
WOCKPHARMA.NS income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
WOCKPHARMA.NS income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
WOCKPHARMA.NS income_statement (quarterly, 2024-12-31) — Tax Provision: 10000000.00
WOCKPHARMA.NS income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.05
WOCKPHARMA.NS income_statement (quarterly, 2024-12-31) — Total Expenses: 6800000000.00
WOCKPHARMA.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items: 0.00
WOCKPHARMA.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
WOCKPHARMA.NS income_statement (quarterly, 2024-12-31) — Write Off: 0.00
WOCKPHARMA.NS income_statement (annual, 2025-03-31) — +Operating Expense: 15320000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 4570000000.00
WOCKPHARMA.NS income_statement (annual, 2025-03-31) — +Total Revenue: 29150000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 7430000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 5920000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 5920000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 6610000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 6610000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -25960000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -25960000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 30580000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 30580000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -1960000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -1960000000.00
WOCKPHARMA.NS income_statement (annual, 2025-03-31) — Amortization: 110000000.00
WOCKPHARMA.NS cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 110000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Assets Held For Sale Current: 1040000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Assets Held For Sale Current: 1040000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 530000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 530000000.00
WOCKPHARMA.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 156909209.00
WOCKPHARMA.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 159235669.00
WOCKPHARMA.NS income_statement (annual, 2025-03-31) — Basic EPS: -3.02
WOCKPHARMA.NS income_statement (quarterly, 2025-03-31) — Basic EPS: -1.57
WOCKPHARMA.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 5050000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 10850000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 10850000000.00
WOCKPHARMA.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -3650000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 1620000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 1620000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 810000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 810000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 1120000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 1120000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 5340000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 5340000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 1120000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 1120000000.00
WOCKPHARMA.NS cash_flow (annual, 2025-03-31) — Change In Inventory: -690000000.00
WOCKPHARMA.NS cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: -1650000000.00
WOCKPHARMA.NS cash_flow (annual, 2025-03-31) — Change In Receivables: -2580000000.00
WOCKPHARMA.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: -4920000000.00
WOCKPHARMA.NS cash_flow (annual, 2025-03-31) — Changes In Cash: -3960000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Common Stock: 810000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 810000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 43530000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 43530000000.00
WOCKPHARMA.NS cash_flow (annual, 2025-03-31) — Common Stock Issuance: 9830000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 5230000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 5230000000.00
WOCKPHARMA.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 12030000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 2600000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Current Assets: 25690000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 25690000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 670000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 670000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Current Debt: 6480000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 6480000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 7150000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 7150000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 20420000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 20420000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 530000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 530000000.00
WOCKPHARMA.NS cash_flow (annual, 2025-03-31) — Depreciation: 2170000000.00
WOCKPHARMA.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 2170000000.00
WOCKPHARMA.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 2170000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 530000000.00
WOCKPHARMA.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 2060000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 530000000.00
WOCKPHARMA.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 157103785.00
WOCKPHARMA.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 159235669.00
WOCKPHARMA.NS income_statement (annual, 2025-03-31) — Diluted EPS: -3.02
WOCKPHARMA.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: -1.57
WOCKPHARMA.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: -470000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -250000000.00
WOCKPHARMA.NS income_statement (annual, 2025-03-31) — EBIT: 2350000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-03-31) — EBIT: 260000000.00
WOCKPHARMA.NS income_statement (annual, 2025-03-31) — EBITDA: 4520000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-03-31) — EBITDA: 790000000.00
WOCKPHARMA.NS cash_flow (annual, 2025-03-31) — Effect Of Exchange Rate Changes: 30000000.00
WOCKPHARMA.NS cash_flow (annual, 2025-03-31) — End Cash Position: 1120000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 0.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 0.00
WOCKPHARMA.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: 4090000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 3340000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 3340000000.00
WOCKPHARMA.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: -3870000000.00
WOCKPHARMA.NS cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: -180000000.00
WOCKPHARMA.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: -30000000.00
WOCKPHARMA.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 1170000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Goodwill: 9770000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Goodwill: 9770000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 25380000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 25380000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 8570000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 8570000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 48370000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 48370000000.00
WOCKPHARMA.NS income_statement (annual, 2025-03-31) — Gross Profit: 17120000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 4830000000.00
WOCKPHARMA.NS income_statement (annual, 2025-03-31) — Interest Expense: 2510000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 480000000.00
WOCKPHARMA.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 2510000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 480000000.00
WOCKPHARMA.NS income_statement (annual, 2025-03-31) — Interest Income: 90000000.00
WOCKPHARMA.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 90000000.00
WOCKPHARMA.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -1640000000.00
WOCKPHARMA.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 160000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Inventory: 7250000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 7250000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 62120000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 62120000000.00
WOCKPHARMA.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -7830000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 0.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 0.00
WOCKPHARMA.NS cash_flow (annual, 2025-03-31) — Issuance Of Capital Stock: 9830000000.00
WOCKPHARMA.NS cash_flow (annual, 2025-03-31) — Issuance Of Debt: 7280000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 2620000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 2620000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 950000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 950000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Long Term Debt: 12110000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 12110000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 13060000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 13060000000.00
WOCKPHARMA.NS cash_flow (annual, 2025-03-31) — Long Term Debt Issuance: 7280000000.00
WOCKPHARMA.NS cash_flow (annual, 2025-03-31) — Long Term Debt Payments: -6860000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 290000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 290000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 28700000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 28700000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Minority Interest: 3040000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Minority Interest: 3040000000.00
WOCKPHARMA.NS income_statement (annual, 2025-03-31) — Minority Interests: 100000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-03-31) — Minority Interests: 200000000.00
WOCKPHARMA.NS cash_flow (annual, 2025-03-31) — Net Common Stock Issuance: 9830000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Net Debt: 17470000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Net Debt: 17470000000.00
WOCKPHARMA.NS cash_flow (annual, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 40000000.00
WOCKPHARMA.NS income_statement (annual, 2025-03-31) — Net Income: -470000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-03-31) — Net Income: -250000000.00
WOCKPHARMA.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: -470000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -250000000.00
WOCKPHARMA.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: -570000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -450000000.00
WOCKPHARMA.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -470000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -250000000.00
WOCKPHARMA.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -470000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -250000000.00
WOCKPHARMA.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: -160000000.00
WOCKPHARMA.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: -570000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -450000000.00
WOCKPHARMA.NS cash_flow (annual, 2025-03-31) — Net Intangibles Purchase And Sale: -2710000000.00
WOCKPHARMA.NS income_statement (annual, 2025-03-31) — Net Interest Income: -2450000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -480000000.00
WOCKPHARMA.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: -4040000000.00
WOCKPHARMA.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: -3390000000.00
WOCKPHARMA.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: 420000000.00
WOCKPHARMA.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -2450000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -480000000.00
WOCKPHARMA.NS cash_flow (annual, 2025-03-31) — Net Other Investing Changes: -400000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Net PPE: 22410000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 22410000000.00
WOCKPHARMA.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -840000000.00
WOCKPHARMA.NS cash_flow (annual, 2025-03-31) — Net Short Term Debt Issuance: -3810000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 18150000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 18150000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Revenue: 660000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 660000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Assets: 5490000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 5490000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 350000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 350000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 290000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 290000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 1520000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 1520000000.00
WOCKPHARMA.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 4520000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 790000000.00
WOCKPHARMA.NS income_statement (annual, 2025-03-31) — Normalized Income: -470000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-03-31) — Normalized Income: -250000000.00
WOCKPHARMA.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: -220000000.00
WOCKPHARMA.NS income_statement (annual, 2025-03-31) — Operating Income: 1800000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-03-31) — Operating Income: 260000000.00
WOCKPHARMA.NS income_statement (annual, 2025-03-31) — Operating Revenue: 29150000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 7430000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 162485569.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 162485569.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 40000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 40000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 130000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 130000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 120000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 120000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 15610000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 15610000000.00
WOCKPHARMA.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: 2160000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 1110000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 1110000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Other Non Current Liabilities: 660000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 660000000.00
WOCKPHARMA.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 530000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 150000000.00
WOCKPHARMA.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 4720000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 2380000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Other Payable: 920000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 920000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Other Properties: 970000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 970000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 540000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 540000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 4220000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 4220000000.00
WOCKPHARMA.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
WOCKPHARMA.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Payables: 6990000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Payables: 6990000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 280000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 280000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 4080000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 4080000000.00
WOCKPHARMA.NS income_statement (annual, 2025-03-31) — Pretax Income: -160000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-03-31) — Pretax Income: -220000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
WOCKPHARMA.NS cash_flow (annual, 2025-03-31) — Provisionand Write Offof Assets: 380000000.00
WOCKPHARMA.NS cash_flow (annual, 2025-03-31) — Purchase Of Intangibles: -2710000000.00
WOCKPHARMA.NS cash_flow (annual, 2025-03-31) — Purchase Of Investment: -4040000000.00
WOCKPHARMA.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -940000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 3370000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 3370000000.00
WOCKPHARMA.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 12030000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 2600000000.00
WOCKPHARMA.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 2170000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 530000000.00
WOCKPHARMA.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 340000000.00
WOCKPHARMA.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 340000000.00
WOCKPHARMA.NS cash_flow (annual, 2025-03-31) — Repayment Of Debt: -10670000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 790000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 790000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 1880000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 1880000000.00
WOCKPHARMA.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 100000000.00
WOCKPHARMA.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 1370000000.00
WOCKPHARMA.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 2540000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Share Issued: 162485569.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 162485569.00
WOCKPHARMA.NS cash_flow (annual, 2025-03-31) — Short Term Debt Payments: -3810000000.00
WOCKPHARMA.NS income_statement (annual, 2025-03-31) — Special Income Charges: 0.00
WOCKPHARMA.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
WOCKPHARMA.NS cash_flow (annual, 2025-03-31) — Stock Based Compensation: 10000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 43530000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 43530000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 18150000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 18150000000.00
WOCKPHARMA.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
WOCKPHARMA.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
WOCKPHARMA.NS income_statement (annual, 2025-03-31) — Tax Provision: 410000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 230000000.00
WOCKPHARMA.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.30
WOCKPHARMA.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.30
WOCKPHARMA.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: 310000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Total Assets: 81350000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 81350000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 55640000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 55640000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Total Debt: 20210000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 20210000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 46570000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 46570000000.00
WOCKPHARMA.NS income_statement (annual, 2025-03-31) — Total Expenses: 27350000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 7170000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 34780000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 34780000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 55660000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 55660000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 14360000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 14360000000.00
WOCKPHARMA.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 30000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 150000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 150000000.00
WOCKPHARMA.NS income_statement (annual, 2025-03-31) — Total Unusual Items: 0.00
WOCKPHARMA.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
WOCKPHARMA.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
WOCKPHARMA.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Work In Process: 540000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Work In Process: 540000000.00
WOCKPHARMA.NS balance_sheet (annual, 2025-03-31) — Working Capital: 5270000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 5270000000.00
WOCKPHARMA.NS income_statement (annual, 2025-03-31) — Write Off: 0.00
WOCKPHARMA.NS income_statement (quarterly, 2025-03-31) — Write Off: 0.00
WOCKPHARMA.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 4290000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 7380000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 162748644.00
WOCKPHARMA.NS income_statement (quarterly, 2025-06-30) — Basic EPS: -5.53
WOCKPHARMA.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 2640000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 560000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 560000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 162748644.00
WOCKPHARMA.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: -5.53
WOCKPHARMA.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -900000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-06-30) — EBIT: -610000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-06-30) — EBITDA: -50000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 4740000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 480000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 480000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-06-30) — Minority Interests: 180000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-06-30) — Net Income: -900000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -900000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -1080000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -900000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -900000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -1080000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -480000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -480000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -50000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 1031100917.43
WOCKPHARMA.NS income_statement (quarterly, 2025-06-30) — Operating Income: 450000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 7380000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 200000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 2020000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
WOCKPHARMA.NS income_statement (quarterly, 2025-06-30) — Pretax Income: -1090000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 2640000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 560000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-06-30) — Special Income Charges: -970000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -8899082.57
WOCKPHARMA.NS income_statement (quarterly, 2025-06-30) — Tax Provision: -10000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.01
WOCKPHARMA.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 6930000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
WOCKPHARMA.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -970000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 4630000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 8880000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 163434903.00
WOCKPHARMA.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 3.61
WOCKPHARMA.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 3170000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 650000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 650000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 163434903.00
WOCKPHARMA.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 3.61
WOCKPHARMA.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 590000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-12-31) — EBIT: 1270000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-12-31) — EBITDA: 1920000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 5710000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 600000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 600000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-12-31) — Minority Interests: -20000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-12-31) — Net Income: 590000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 590000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 610000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 590000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 590000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 610000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -600000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -600000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 2020000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 681044776.12
WOCKPHARMA.NS income_statement (quarterly, 2025-12-31) — Operating Income: 1080000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 8880000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 250000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 2170000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
WOCKPHARMA.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 670000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 3170000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 650000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: -100000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -8955223.88
WOCKPHARMA.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 60000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.09
WOCKPHARMA.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 7800000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: -100000000.00
WOCKPHARMA.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -100000000.00
WOCKPHARMA.NS income_statement (annual, 2026-03-31) — +Operating Expense: 17010000000.00
WOCKPHARMA.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 5040000000.00
WOCKPHARMA.NS income_statement (annual, 2026-03-31) — +Total Revenue: 33170000000.00
WOCKPHARMA.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 9650000000.00
WOCKPHARMA.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 5630000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 5630000000.00
WOCKPHARMA.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 5880000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 5880000000.00
WOCKPHARMA.NS balance_sheet (annual, 2026-03-31) — Accumulated Depreciation: -28620000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -28620000000.00
WOCKPHARMA.NS balance_sheet (annual, 2026-03-31) — Additional Paid In Capital: 30590000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 30590000000.00
WOCKPHARMA.NS balance_sheet (annual, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -1220000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -1220000000.00
WOCKPHARMA.NS income_statement (annual, 2026-03-31) — Amortization: 290000000.00
WOCKPHARMA.NS balance_sheet (annual, 2026-03-31) — Assets Held For Sale Current: 910000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2026-03-31) — Assets Held For Sale Current: 910000000.00
WOCKPHARMA.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 720000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 720000000.00
WOCKPHARMA.NS income_statement (annual, 2026-03-31) — Basic Average Shares: 162489601.00
WOCKPHARMA.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 162267840.00
WOCKPHARMA.NS income_statement (annual, 2026-03-31) — Basic EPS: 13.12
WOCKPHARMA.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 10.23
WOCKPHARMA.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 1120000000.00
WOCKPHARMA.NS balance_sheet (annual, 2026-03-31) — Buildings And Improvements: 11230000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 11230000000.00
WOCKPHARMA.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -3640000000.00
WOCKPHARMA.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 1080000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 1080000000.00
WOCKPHARMA.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 810000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 810000000.00
WOCKPHARMA.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 2170000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 2170000000.00
WOCKPHARMA.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 6290000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 6290000000.00
WOCKPHARMA.NS balance_sheet (annual, 2026-03-31) — Cash Financial: 2170000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2026-03-31) — Cash Financial: 2170000000.00
WOCKPHARMA.NS cash_flow (annual, 2026-03-31) — Change In Inventory: -1120000000.00
WOCKPHARMA.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: -2200000000.00
WOCKPHARMA.NS cash_flow (annual, 2026-03-31) — Change In Receivables: 500000000.00
WOCKPHARMA.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -2820000000.00
WOCKPHARMA.NS cash_flow (annual, 2026-03-31) — Changes In Cash: 950000000.00
WOCKPHARMA.NS balance_sheet (annual, 2026-03-31) — Common Stock: 810000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 810000000.00
WOCKPHARMA.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 49400000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 49400000000.00
WOCKPHARMA.NS cash_flow (annual, 2026-03-31) — Common Stock Issuance: 0.00
WOCKPHARMA.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 6840000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 6840000000.00
WOCKPHARMA.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 12130000000.00
WOCKPHARMA.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 3180000000.00
WOCKPHARMA.NS balance_sheet (annual, 2026-03-31) — Current Assets: 26970000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 26970000000.00
WOCKPHARMA.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 700000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 700000000.00
WOCKPHARMA.NS balance_sheet (annual, 2026-03-31) — Current Debt: 6070000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 6070000000.00
WOCKPHARMA.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 6770000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 6770000000.00
WOCKPHARMA.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 16220000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 16220000000.00
WOCKPHARMA.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 340000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 340000000.00
WOCKPHARMA.NS cash_flow (annual, 2026-03-31) — Depreciation: 2270000000.00
WOCKPHARMA.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 2270000000.00
WOCKPHARMA.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 2270000000.00
WOCKPHARMA.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 530000000.00
WOCKPHARMA.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 1980000000.00
WOCKPHARMA.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 530000000.00
WOCKPHARMA.NS income_statement (annual, 2026-03-31) — Diluted Average Shares: 162645470.00
WOCKPHARMA.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 162426614.00
WOCKPHARMA.NS income_statement (annual, 2026-03-31) — Diluted EPS: 13.10
WOCKPHARMA.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 10.22
WOCKPHARMA.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 2130000000.00
WOCKPHARMA.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 1660000000.00
WOCKPHARMA.NS income_statement (annual, 2026-03-31) — EBIT: 4460000000.00
WOCKPHARMA.NS income_statement (quarterly, 2026-03-31) — EBIT: 2390000000.00
WOCKPHARMA.NS income_statement (annual, 2026-03-31) — EBITDA: 6730000000.00
WOCKPHARMA.NS income_statement (quarterly, 2026-03-31) — EBITDA: 2920000000.00
WOCKPHARMA.NS cash_flow (annual, 2026-03-31) — Effect Of Exchange Rate Changes: 140000000.00
WOCKPHARMA.NS cash_flow (annual, 2026-03-31) — End Cash Position: 2170000000.00